BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2443077)

  • 21. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (VEPA) for non-Hodgkin's lymphoma].
    Saaki A; Yokomatsu Y; Kojima K; Yoshikawa T; Sannomiya Y; Tatsumi J; Hashimoto K; Park K; Kawarabayashi K; Yoshikawa C
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):65-9. PubMed ID: 3753642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
    Yamane T; Hino M; Ohta K; Koh KR; Nakamae H; Aoyama Y; Ota T; Kishida T; Mugitani A; Sannomiya Y; Kamitani T; Takubo T; Tatsumi N
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1547-55. PubMed ID: 11016000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
    Bonadonna G; Monfardini S; Villa E
    Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the additive potential of teniposide and vincristine in non-Hodgkin's lymphoma. Australian and New Zealand Lymphoma Group.
    Cancer Treat Rep; 1986 Aug; 70(8):985-90. PubMed ID: 2873890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
    Motomura S; Hashimoto C; Kodama F; Maruta A; Sakai R; Fujita H; Tomita N; Fujisawa S; Harano H; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 May; 46(5):350-7. PubMed ID: 16444968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
    Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
    Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epirubicin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma: with emphasis of elderly patients].
    Sampi K; Takouda K; Hattori M
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1925-8. PubMed ID: 2393310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Patterns of relapse in non-Hodgkin's lymphoma after complete remission induced by combination chemotherapy].
    Yamazaki H; Kuraishi Y; Takasaki N; Ozeki H; Mashizu N; Nagamine D; Usui N; Nakamura T; Aiba K; Yokoyama K
    Rinsho Ketsueki; 1985 Dec; 26(12):1936-41. PubMed ID: 2422407
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy in advanced non-Hodgkin's lymphoma: follow-up studies].
    Kimura I
    Nihon Rinsho; 1983 Nov; 41(11):2600-10. PubMed ID: 6200629
    [No Abstract]   [Full Text] [Related]  

  • 33. [A bulky mass non-Hodgkin's lymphoma with dysuria in the rectovesical space].
    Tosaka A; Yamazaki A; Hirokawa M; Matsushita K; Asakura S
    Hinyokika Kiyo; 1990 Jun; 36(6):701-5. PubMed ID: 2239564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
    Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [COBDP combination chemotherapy in the treatment of malignant lymphoma--report on 64 patients].
    Jin XQ
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):295-8. PubMed ID: 1806351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy of advanced non-Hodgkin's lymphoma with adriamycin, vincristine, ifosfamide and prednisolone (AVIP): a preliminary report.
    Ohnoshi T; Oka A; Hayashi K; Ueoka H; Sato M; Nishihara R; Yasuoka M; Sando Y; Tanaka T; Kimura I
    Acta Med Okayama; 1982 Feb; 36(1):67-72. PubMed ID: 7064735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer].
    Akimoto S; Akakura K; Masai M; Shimazaki J
    Hinyokika Kiyo; 1991 Jan; 37(1):31-7. PubMed ID: 1707216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphoma.
    Takagi T; Sakai C; Oguro M
    Oncology; 1990; 47(1):25-8. PubMed ID: 2300381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immuno-chemotherapy of malignant lymphoma using OK-432, a streptococcal agent.
    Kimura I; Ohnoshi T; Nakata Y; Takasugi K; Fujii M; Hayashi K; Kataoka M; Sato M; Nishihara R
    Acta Med Okayama; 1979 Dec; 33(6):471-8. PubMed ID: 94239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The significance of reinduction chemotherapy with adriamycin for relapsed non-Hodgkin's lymphoma of Waldeyer's ring].
    Takenaka T; Minato K; Nagai M; Kitahara T; Shimoyama M; Sakano T; Konda C
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1675-80. PubMed ID: 4040735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.